Evidence map›Paper›PMID 35840592›Full record

ArticleScientific reports2022

Transmission history of SARS-CoV-2 in humans and white-tailed deer.

Katriina Willgert, Xavier Didelot, Meera Surendran-Nair, Suresh V Kuchipudi, Rachel M Ruden, Michele Yon, Ruth H Nissly, Kurt J Vandegrift, Rahul K Nelli, Lingling Li and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Katriina WillgertDisease Dynamics Unit (DDU), Department of Veterinary Medicine, University of Cambridge, Cambridge, UK. kw473@cam.ac.uk.
Xavier DidelotSchool of Life Sciences and Department of Statistics, University of Warwick, Coventry, UK.
Meera Surendran-NairAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Suresh V KuchipudiAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Rachel M RudenWildlife Bureau, Iowa Department of Natural Resources, Des Moines, IA, USA.
Michele YonAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Ruth H NisslyAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Kurt J VandegriftThe Center for Infectious Disease Dynamics, Department of Biology and Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Rahul K NelliDepartment of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Lingling LiAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Bhushan M JayaraoAnimal Diagnostic Laboratory, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Nicole LevineHuck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Randall J OlsenLaboratory of Molecular and Translational Human Infectious Disease Research, Center for Infectious Diseases, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, 77030, USA.
James J DavisUniversity of Chicago Consortium for Advanced Science and Engineering, University of Chicago, Chicago, USA.
James M MusserLaboratory of Molecular and Translational Human Infectious Disease Research, Center for Infectious Diseases, Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, 77030, USA.
Peter J HudsonThe Center for Infectious Disease Dynamics, Department of Biology and Huck Institutes of the Life Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Vivek KapurHuck Institutes of Life Sciences, The Pennsylvania State University, University Park, PA, 16802, USA.
Andrew J K ConlanDisease Dynamics Unit (DDU), Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Pennsylvania State University · USCenter for Disease Dynamics, Economics & Policy · USCornell University · USUniversity of Cambridge · GBIowa Department of Natural Resources · USIowa State University · USUniversity of Chicago · USUniversity of Warwick · GB

Funding

BIOINFORMATICS RESOURCE CENTERS FOR INFECTIOUS DISEASES: SARS-CoV-2 ACTIVITIES75N93019C00076 · NIAID · UNIVERSITY OF CHICAGO · PI STEVENS, RICK · 2019 to 2023
$32.6M
Carbon nanotube integrated microdevice for next generation sequencing based virus discoveryR01AI134911 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI ZHENG, SIYANG · 2018 to 2022
$2.0M
Infection and prevalence of a new segmented flavivirus in the United StatesR21AI156406 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KAPOOR, AMIT · 2021 to 2022
$440k
Biotechnology and Biological Sciences Research Council BB/M011194/1Department of HealthNIAID NIH HHS 75N93019C00076NIAID NIH HHS R01 AI134911NIAID NIH HHS R21 AI156406
6 · The paper itself

Abstract

The emergence of a novel pathogen in a susceptible population can cause rapid spread of infection. High prevalence of SARS-CoV-2 infection in white-tailed deer (Odocoileus virginianus) has been reported in multiple locations, likely resulting from several human-to-deer spillover events followed by deer-to-deer transmission. Knowledge of the risk and direction of SARS-CoV-2 transmission between humans and potential reservoir hosts is essential for effective disease control and prioritisation of interventions. Using genomic data, we reconstruct the transmission history of SARS-CoV-2 in humans and deer, estimate the case finding rate and attempt to infer relative rates of transmission between species. We found no evidence of direct or indirect transmission from deer to human. However, with an estimated case finding rate of only 4.2%, spillback to humans cannot be ruled out. The extensive transmission of SARS-CoV-2 within deer populations and the large number of unsampled cases highlights the need for active surveillance at the human-animal interface.

Indexed as

COVID-19DeerSARS-CoV-2Viral ZoonosesAnimalsEnvironmental MonitoringHumansRisk Assessment

Identifiers

PMID35840592
PMCPMC9284484
OpenAlexW4285590599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.